Reviving the FDA | Health Policy and Reform
Links shared publicly online about this topic.
- 816total visits
Reviving the FDA | Health Policy and Reform
healthpolicyandreform.nejm.org —
View full resource at healthpolicyandreform.nejm.org
Tags: Drug, Healthy Living, FDA
Most Recently Shared on October 14, 2010 at 12:41 am By:
Also Shared By:
FDA Takes Step To Preserve The Effectiveness Of Cephalosporin Drugs For Treating Disease In Humans - Better Health
getbetterhealth.com — “Better Health is a network of healthcare professional blogs, offering commentary on news, research, health policy, healthcare reform, true stories, disease management and expert interviews.” View full resource at getbetterhealth.com
Most Recently Shared on January 6, 2012 at 7:19 pm By:
drval Health Social Media, Physician, and Doctor
New Post: FDA Takes Step To Preserve The Effectiveness Of Cephalosporin Drugs For Treating Disease In Humans: C... http://t.co/YFHH5p6j
FDA Requires Label Changes For The Patch - Better Health
getbetterhealth.com — “Better Health is a network of healthcare professional blogs, offering commentary on news, research, health policy, healthcare reform, true stories, disease management and expert interviews.” View full resource at getbetterhealth.com
Most Recently Shared on December 13, 2011 at 11:41 pm By:
Julie Bohlen Health Executive and Active Health Library
FDA Requires Label Changes For The Patch: After cautiously clearing Yaz for continued use Thursday, an FD... http://t.co/1Db1ezQF #news
FDA Approves Tetanus/Diphtheria/Pertussis Vaccine For Adults Over 65 - Better Health
getbetterhealth.com — “Better Health is a network of healthcare professional blogs, offering commentary on news, research, health policy, healthcare reform, true stories, disease management and expert interviews.” View full resource at getbetterhealth.com
Most Recently Shared on November 5, 2011 at 9:58 pm By:
drval Health Social Media, Physician, and Doctor
New Post: FDA Approves Tetanus/Diphtheria/Pertussis Vaccine For Adults Over 65: Most of us are familiar with the... http://t.co/6nDdawB7
Is The FDA Too Lenient When Reviewing Medical Devices? - Better Health
getbetterhealth.com — “Better Health is a network of healthcare professional blogs, offering commentary on news, research, health policy, healthcare reform, true stories, disease management and expert interviews.” View full resource at getbetterhealth.com
Most Recently Shared on September 21, 2011 at 5:14 pm By:
Roger D. Jones, PhD Health Executive, Health Social Media, PhD, and Doctor
Is The FDA Too Lenient When Reviewing Medical Devices? - Better Health http://t.co/5nr6lmnc #health #medicine
FDA Asks For Input From Clinicians About Mobile Apps In Medicine - Better Health
getbetterhealth.com — “Better Health is a network of healthcare professional blogs, offering commentary on news, research, health policy, healthcare reform, true stories, disease management and expert interviews.” View full resource at getbetterhealth.com
Most Recently Shared on September 20, 2011 at 2:07 pm By:
drval Health Social Media, Physician, and Doctor
New Post: FDA Asks For Input From Clinicians About Mobile Apps In Medicine: The publication in July of the FDA D... http://t.co/ecpG2OlR
FDA Approves A New, Monoclonal Antibody For Lymphoma - Better Health
getbetterhealth.com — “Better Health is a network of healthcare professional blogs, offering commentary on news, research, health policy, healthcare reform, true stories, disease management and expert interviews.” View full resource at getbetterhealth.com
Most Recently Shared on August 29, 2011 at 9:24 pm By:
Julie Bohlen Health Executive and Active Health Library
FDA Approves A New, Monoclonal Antibody For Lymphoma: Recently, the FDA announced its approval, upon acce... http://t.co/EB5I1vj #news
FDA and Electronic Health Records - Policy and Medicine
policymed.com — “Electronic health records (EHRs) have been a hot topic in health care reform over the past several years. Many believe that EHRs hold promise for reducing costs, improving the quality and efficiency of care, and reducing medical errors. As numerous...” View full resource at policymed.com
Most Recently Shared on August 16, 2011 at 12:40 pm By:
Dennis Urbaniak Health Executive, Health Social Media, and Pharma
FDA and Electronic Health Records via Policy and Medicine Blog http://ow.ly/64jdC #yam
Developing the Nation’s Biosimilars Program | Health Policy and Reform
healthpolicyandreform.nejm.org — “Steven Kozlowski, M.D., Janet Woodcock, M.D., Karen Midthun, M.D., and Rachel Behrman Sherman, M.D., M.P.H. Biologic products developed over the past” View full resource at healthpolicyandreform.nejm.org
Most Recently Shared on August 9, 2011 at 2:54 pm By:
eyeonfda Pharma and Health Lawyer
RT @the_pillbook: FDA speaks: The next step in developing biosimilars in the US.http://healthpolicyandreform.nejm.org/?p=15048&query=TOC
FDA Announces Regulations Regarding Medical Mobile Apps - Better Health
getbetterhealth.com — “Better Health is a network of healthcare professional blogs, offering commentary on news, research, health policy, healthcare reform, true stories, disease management and expert interviews.” View full resource at getbetterhealth.com
Most Recently Shared on August 3, 2011 at 12:24 pm By:
Julie Bohlen Health Executive and Active Health Library
FDA Announces Regulations Regarding Medical Mobile Apps: FDA has published an announcement about regulatio... http://bit.ly/oVPPbM #news
The New Details About The FDA Regulation Of mHealth Apps - Better Health
getbetterhealth.com — “Better Health is a network of healthcare professional blogs, offering commentary on news, research, health policy, healthcare reform, true stories, disease management and expert interviews.” View full resource at getbetterhealth.com
Most Recently Shared on July 25, 2011 at 1:54 pm By:
Mark Scrimshire Patient Advocate and Health Social Media
Trick will be to avoid stifling innovation RT @ReynaLinares: #FDA to regulate growing number of medical mobile apps. http://t.co/0STmx6Q
The New Details About The FDA Regulation Of mHealth Apps - Better Health
getbetterhealth.com — “Better Health is a network of healthcare professional blogs, offering commentary on news, research, health policy, healthcare reform, true stories, disease management and expert interviews.” View full resource at getbetterhealth.com
Most Recently Shared on July 23, 2011 at 4:21 pm By:
Julie Bohlen Health Executive and Active Health Library
The New Details About The FDA Regulation Of mHealth Apps: Since the beginning of this year, there have bee... http://bit.ly/r5fkhl #news
The Bottom Line On New FDA Sunscreen Guidelines - Better Health
getbetterhealth.com — “Better Health is a network of healthcare professional blogs, offering commentary on news, research, health policy, healthcare reform, true stories, disease management and expert interviews.” View full resource at getbetterhealth.com
Most Recently Shared on July 5, 2011 at 6:17 pm By:
Strataderm for Scars Pharma and Health Social Media
Better Health - The Bottom Line On New FDA Sunscreen Guidelines http://t.co/QxJB7VL #health
FDA-Approved Drugs Are Not Always Effective: The Benefits Of Alternative Medicine - Better Health
getbetterhealth.com — “Better Health is a network of healthcare professional blogs, offering commentary on news, research, health policy, healthcare reform, true stories, disease management and expert interviews.” View full resource at getbetterhealth.com
Most Recently Shared on June 25, 2011 at 9:11 pm By:
RT @drval FDA-Approved Drugs Are Not Always Effective: The Benefits Of Alternative Medicine.. http://bit.ly/jkXri9
Weighing the Benefits of High-Dose Simvastatin against the Risk of Myopathy | Health Policy and Reform
healthpolicyandreform.nejm.org — “Amy Egan, M.D., M.P.H., and Eric Colman, M.D. Statins are the most widely prescribed class of drugs for treating dyslipidemia — in particular, elevated” View full resource at healthpolicyandreform.nejm.org
Most Recently Shared on June 16, 2011 at 1:24 am By:
Physician Assistants Health News Feed
Weighing Benefits of High-Dose Simvastatin against the Risk of Myopathy: http://bit.ly/lHvmmC FDA will closely monitor prescription-use data
New FDA Regulation to Improve Safety Reporting in Clinical Trials | Health Policy and Reform
healthpolicyandreform.nejm.org — “Rachel Behrman Sherman, M.D., M.P.H., Janet Woodcock, M.D., Janet Norden, M.S.N., R.N., Cheryl Grandinetti, Pharm.D., and Robert J. Temple, M.D. As part” View full resource at healthpolicyandreform.nejm.org
Most Recently Shared on June 9, 2011 at 2:23 am By:
Juan C. Ivancevich, MD Physician, Doctor, Internist, and Allergist
New safety-reporting paradigm for drugs being studied under investigational new drug applications http://bit.ly/lRUIOi
Advertisement
NEJM
@NEJM
Susan Okie interviews FDA’s Hamburg and Sharfstein on making the agency more nimble and proactive. http://bit.ly/aXUn7I
1 year ago...